Corient Private Wealth’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Sell
16,309
-3,630
-18% -$85.6K ﹤0.01% 2473
2026
Q1
$446K Sell
19,939
-43,013
-68% -$1.02M ﹤0.01% 2094
2025
Q4
$414K Buy
62,952
+54,340
+631% +$1.61M ﹤0.01% 2422
2025
Q3
$261K Sell
8,612
-1,614
-16% -$48.9K ﹤0.01% 2202
2025
Q2
$321K Buy
10,226
+2,599
+34% +$86K ﹤0.01% 1953
2025
Q1
$291K Buy
+7,627
New +$324K ﹤0.01% 1870

Other funds holding ENOV

Corient Private Wealth's ENOV Position: Q2 2026 in Review

Corient Private Wealth reduced its Enovis (ENOV) stake by 18% in Q2 2026, selling an estimated $85.6K and leaving 16,309 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2473.

Corient Private Wealth first reported a position in ENOV in Q1 2025 and has held it in 6 quarters since. The position peaked at $446K in Q1 2026. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Corient Private Wealth held 16,309 shares of Enovis worth $338K as of Q2 2026.
  • Corient Private Wealth sold 3,630 Enovis shares in Q2 2026, an estimated $85.6K.
  • Enovis made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2473 holding.
  • Corient Private Wealth first reported a position in Enovis in Q1 2025 and has held it in 6 quarters since.
  • Corient Private Wealth's Enovis position peaked at $446K in Q1 2026.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.